切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2017, Vol. 06 ›› Issue (02) : 150 -152. doi: 10.3877/cma.j.issn.2095-3232.2017.02.018

所属专题: 文献

专题笔谈

肝细胞癌微血管侵犯诊治
段小飞1, 张水军1,()   
  1. 1. 450052 郑州大学第一附属医院肝胆胰外科 河南省消化器官移植重点实验室 河南省高等学校肝胆胰外科与消化器官移植重点学科开放实验室 郑州市肝胆胰疾病与器官移植医学重点实验室
  • 收稿日期:2016-11-05 出版日期:2017-04-10
  • 通信作者: 张水军
  • 基金资助:
    河南省卫计委医学科技攻关项目(201401003); 河南省科技厅科技攻关项目(152102310060); 郑州市创新团队项目(131PCXTD617)

Diagnosis and treatment for microvascular invasion of hepatocellular carcinoma

Xiaofei Duan1, Shuijun Zhang1()   

  • Received:2016-11-05 Published:2017-04-10
  • Corresponding author: Shuijun Zhang
引用本文:

段小飞, 张水军. 肝细胞癌微血管侵犯诊治[J/OL]. 中华肝脏外科手术学电子杂志, 2017, 06(02): 150-152.

Xiaofei Duan, Shuijun Zhang. Diagnosis and treatment for microvascular invasion of hepatocellular carcinoma[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2017, 06(02): 150-152.

[1]
Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015, 65(2):87-108.
[2]
中国抗癌协会肝癌专业委员会,中华医学会肝病学分会肝癌学组,中国抗癌协会病理专业委员会,等.原发性肝癌规范化病理诊断指南(2015年版)[J].中华肝胆外科杂志,2015,21(3):145-151.
[3]
Strilic B, Yang L, Albarrán-Juárez J, et al. Tumour-cell-induced endothelial cell necroptosis via death receptor 6 promotes metastasis[J]. Nature, 2016, 536(7615):215-218.
[4]
Ding T, Xu J, Zhang Y, et al. Endothelium-coated tumor clusters are associated with poor prognosis and micrometastasis of hepatocellular carcinoma after resection[J]. Cancer, 2011, 117(21):4878-4889.
[5]
Banerjee S, Wang DS, Kim HJ, et al. A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinoma[J]. Hepatology, 2015, 62(3):792-800.
[6]
Chandarana H, Robinson E, Hajdu CH, et al. Microvascular invasion in hepatocellular carcinoma: is it predictable with pretransplant MRI?[J]. AJR Am J Roentgenol, 2011, 196(5):1083-1089.
[7]
Min JH, Kim YK, Lim S, et al. Prediction of microvascular invasion of hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging: impact of intra-tumoral fat detected on chemical-shift images[J]. Eur J Radiol, 2015, 84(6):1036-1043.
[8]
Suh YJ, Kim MJ, Choi JY, et al. Preoperative prediction of the microvascular invasion of hepatocellular carcinoma with diffusion-weighted imaging[J]. Liver Transpl, 2012, 18(10):1171-1178.
[9]
Cheung TT, Chan SC, Ho CL, et al. Can positron emission tomography with the dual tracers [11C] acetate and [18F] fludeoxyglucose predict microvascular invasion in hepatocellular carcinoma?[J]. Liver Transpl, 2011, 17(10):1218-1225.
[10]
Poté N, Cauchy F, Albuquerque M, et al. Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion[J]. J Hepatol, 2015, 62(4):848-854.
[11]
Huang C, Wang Y, Liu S, et al. Quantitative proteomic analysis identified paraoxonase 1 as a novel serum biomarker for microvascular invasion in hepatocellular carcinoma[J]. J Proteome Res, 2013, 12(4):1838-1846.
[12]
Poté N, Alexandrov T, Le Faouder J, et al. Imaging mass spectrometry reveals modified forms of histone H4 as new biomarkers of microvascular invasion in hepatocellular carcinomas[J]. Hepatology, 2013, 58(3):983-994.
[13]
Shirabe K, Toshima T, Kimura K, et al. New scoring system for prediction of microvascular invasion in patients with hepatocellular carcinoma[J]. Liver Int, 2014, 34(6):937-941.
[14]
Wu J, Sun H, Han Z, et al. A single center experience: post-transplantation adjuvant chemotherapy impacts the prognosis of hepatocellular carcinoma patients[J]. Chin Med J, 2014, 127(3):430-434.
[15]
Hou YF, Li B, Wei YG, et al. Second hepatectomy improves survival in patients with microvascular invasive hepatocellular carcinoma meeting the Milan criteria[J]. Medicine, 2015, 94(48):e2070.
[16]
Jin YJ, Lee JW, Lee OH, et al. Transarterial chemoembolization versus surgery/radiofrequency ablation for recurrent hepatocellular carcinoma with or without microvascular invasion[J]. J Gastroenterol Hepatol, 2014, 29(5):1056-1064.
[17]
Wang SN, Chuang SC, Lee KT. Efficacy of sorafenib as adjuvant therapy to prevent early recurrence of hepatocellular carcinoma after curative surgery: a pilot study[J]. Hepatol Res, 2014, 44(5):523-531.
[18]
朱阳波,徐骁,郑树森.小肝癌患者微血管侵犯与肝移植后肿瘤复发及预后相关性研究[J].浙江大学学报(医学版),2014(6):658-663.
[19]
Sumie S, Nakashima O, Okuda K, et al. The significance of classifying microvascular invasion in patients with hepatocellular carcinoma[J]. Ann Surg Oncol, 2014, 21(3):1002-1009.
[20]
陈星,李强,荀晓冬,等.微血管侵犯对单发小肝癌患者术后无进展生存期的影响[J].中华肝胆外科杂志,2016,22(2):94-98.
[21]
Du M, Chen L, Zhao J, et al. Microvascular invasion (MVI) is a poorer prognostic predictor for small hepatocellular carcinoma[J]. BMC Cancer, 2014(14):38.
[22]
Yamashita Y, Tsuijita E, Takeishi K, et al. Predictors for microinvasion of small hepatocellular carcinoma ≤ 2 cm[J]. Ann Surg Oncol, 2012, 19(6):2027-2034.
[23]
Shindoh J, Andreou A, Aloia TA, et al. Microvascular invasion does not predict long-term survival in hepatocellular carcinoma up to 2 cm: reappraisal of the staging system for solitary tumors[J]. Ann Surg Oncol, 2013, 20(4):1223-1229.
[1] 中国医师协会肝癌专业委员会. 肝细胞癌伴微血管侵犯诊断和治疗中国专家共识(2024版)[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 313-324.
[2] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[3] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[4] 屈翔宇, 张懿刚, 李浩令, 邱天, 谈燚. USP24及其共表达肿瘤代谢基因在肝细胞癌中的诊断和预后预测作用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 659-662.
[5] 公宇, 廖媛, 尚梅. 肝细胞癌TACE术后复发影响因素及预测模型建立[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 818-824.
[6] 李一帆, 朱帝文, 任伟新, 鲍应军, 顾俊鹏, 张海潇, 曹耿飞, 阿斯哈尔·哈斯木, 纪卫政. 血GP73水平在原发性肝癌TACE疗效评价中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 825-830.
[7] 刘敏思, 李荣, 李媚. 基于GGT与Plt比值的模型在HBV相关肝细胞癌诊断中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 831-835.
[8] 焦振东, 惠鹏, 金上博. 三维可视化结合ICG显像技术在腹腔镜肝切除术治疗复发性肝癌中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 859-864.
[9] 陈晓鹏, 王佳妮, 练庆海, 杨九妹. 肝细胞癌VOPP1表达及其与预后的关系[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 876-882.
[10] 袁雨涵, 杨盛力. 体液和组织蛋白质组学分析在肝癌早期分子诊断中的研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 883-888.
[11] 吴警, 吐尔洪江·吐逊, 温浩. 肝切除术前肝功能评估新进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 889-893.
[12] 邓万玉, 陈富, 许磊波. 肝硬化与非肝硬化乙肝相关性肝癌患者术后无复发生存比较及其影响因素分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 670-674.
[13] 王向前, 李清峰, 陈磊, 丘文丹, 姚志成, 李熠, 吴荣焕. 姜黄素抑制肝细胞癌索拉非尼耐药作用及其调控机制[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 729-735.
[14] 龚财芳, 赵俊宇, 游川. 围手术期肠内营养在肝癌肝切除患者中有效性及安全性的Meta分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 551-556.
[15] 王璇, 娜扎开提·尼加提, 雒洋洋, 蒋升. 皮肤晚期糖基化终末产物浓度与2型糖尿病微血管并发症的相关性[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 447-454.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?